Quick Takeaways
- AWM Investment Company, Inc. filed SCHEDULE 13G/A for AYTU BIOPHARMA, INC Common Stock, Par Value $0.0001 (ASPI).
- Disclosed ownership: 5.8%.
- Date of event: 31 Dec 2025.
AWM Investment Company, Inc. - 31 Dec 2025 SCHEDULE 13G/A Report for AYTU BIOPHARMA, INC Common Stock, Par Value $0.0001 (ASPI)
- Filing Manager
- AWM Investment Company, Inc.
- Reporting Manager
- AWM Investment Company, Inc.
- Symbol
- ASPI
- Shares outstanding
- 10,682,310 shares
- Disclosed Ownership
- 619,574 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 14:35:51 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"AWM Investment Company, Inc. disclosed 5.8% ownership in AYTU BIOPHARMA, INC Common Stock, Par Value $0.0001 (ASPI) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 13 Feb 2026, 14:35.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AWM Investment Company, Inc. | 5.8% | 619,574 | 619,574 | 0 | Adam Stettner | Executive Vice President |